^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

Venclexta (venetoclax)

i
Other names: ABT-199, RG 7601, GDC-0199, RG7601, RG-7601, GDC 0199, A-1195425.0, ABT199, ABT 199, RO-5537382, ABT-0199
Company:
AbbVie, Roche, Walter and Eliza Hall Institute
Drug class:
Bcl2 inhibitor
Related drugs:
8ms
IDH1 (Isocitrate dehydrogenase (NADP(+)) 1)
|
IDH1 mutation
|
Venclexta (venetoclax) • azacitidine • Tibsovo (ivosidenib)
9ms
IDH1 (Isocitrate dehydrogenase (NADP(+)) 1)
|
IDH1 mutation
|
Venclexta (venetoclax) • azacitidine • Tibsovo (ivosidenib)
9ms
IDH1 (Isocitrate dehydrogenase (NADP(+)) 1)
|
IDH1 mutation
|
Venclexta (venetoclax) • azacitidine • Tibsovo (ivosidenib)
9ms
IDH1 (Isocitrate dehydrogenase (NADP(+)) 1)
|
IDH1 mutation
|
Venclexta (venetoclax) • azacitidine • Tibsovo (ivosidenib)
10ms
IDH1 (Isocitrate dehydrogenase (NADP(+)) 1)
|
IDH1 mutation
|
Venclexta (venetoclax) • azacitidine • Tibsovo (ivosidenib)
10ms
Venclexta (venetoclax)